Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention
Overview
Authors
Affiliations
Background: Despite the potential benefits of diet and physical activity, evidence for beneficial effects of a combined lifestyle intervention is lacking in patients with inflammatory bowel disease (IBD). Therefore, we assessed its effects on impact of disease on daily life, clinical disease activity, fatigue, and health-related quality of life (HRQoL) in patients with IBD.
Methods: A 6-month single-arm intervention study was performed in adult IBD patients in remission or with mildly active disease. Participants received personal dietary and physical activity advice from a dietician and a physiotherapist in 6 consults. At baseline and over time, questionnaires on diet quality, physical activity, and disease-related outcomes were completed and fecal calprotectin was determined. Data were analyzed by linear mixed models.
Results: During the intervention, diet quality significantly increased (P < .001), but the level of physical activity remained the same. Over time, impact of the disease on daily life reduced (P = .009) and fatigue decreased (P = .001), while clinical disease activity, HRQoL, and fecal calprotectin did not change. Improvement in diet quality was significantly associated with a lower impact of disease on daily life (β = 0.09; 95% confidence interval [CI], 0.03 to 0.15; P = .003) and less fatigue (β = -0.13; 95% CI, -0.20 to -0.07; P < .001) but not with clinical disease activity, HRQoL, and fecal calprotectin. No associations were found with physical activity.
Conclusions: This combined lifestyle intervention significantly improved diet quality, and this improvement was associated with a reduction in the impact of disease on daily life and fatigue in patients with IBD in remission or with mildly active disease.
Horvat B, Orban K, David A, Sallay V, Rafael B, Njers S Therap Adv Gastroenterol. 2024; 17:17562848241275315.
PMID: 39290331 PMC: 11406597. DOI: 10.1177/17562848241275315.
Truyens M, Lernout H, De Vos M, Laukens D, Lobaton T Front Med (Lausanne). 2024; 11:1424926.
PMID: 39021817 PMC: 11252009. DOI: 10.3389/fmed.2024.1424926.
DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.
Sandys O, Stokkers P, Te Velde A Dig Dis Sci. 2024; 70(1):49-73.
PMID: 38963463 PMC: 11761125. DOI: 10.1007/s10620-024-08523-5.
Perceptions, behaviours and barriers towards exercise practices in inflammatory bowel disease.
Sinclair J, Brooks-Warburton J, Bottoms L PLoS One. 2024; 19(4):e0299228.
PMID: 38578737 PMC: 10997097. DOI: 10.1371/journal.pone.0299228.
Lu W, Cen J, Dai Q, Tao H, Peng L Front Immunol. 2024; 14:1296889.
PMID: 38288127 PMC: 10822939. DOI: 10.3389/fimmu.2023.1296889.